We demonstrated that overexpression of miR-125a-3p down-regulated the expression of Akt, a key regulator of survival during cellular stress (20, 21), making miR-125a-3p a unique potential target for anti-cancer therapy (22). This evidence concerns the gene AKT1 and cancer.